Tx3 provided quality and compliance software testing solutions to life-sciences organizations with their Vera platform. Vera was faster, more efficient and more accurate than the traditional, manual approach many groups used, and became a critical tool for their clients.

But Vera’s growing popularity raised some challenges:

• Tx3’s infrastructure was solid but needed to scale faster; each new client required many manual set-up processes that took a long time.
• Clients kept requesting new features, so Tx3 needed to constantly put out updated versions of Vera.
• Healthcare is heavily regulated, and Tx3 needed a team who knew healthcare.

Plan A’s engineers joined Tx3’s development efforts, making Vera easier to configure and use, more functional, and more scalable. We also developed automations that simplified the process of creating new instances.

This was a game changer for Tx3, as it turned a long, difficult manual process into an easy task. And we built integrations to key third-party vendors and external applications like Jira, which became a huge selling point for the product.

Vera is now a vital part of the healthcare landscape. Major life sciences clients, like Johnson & Johnson and Merck, have come to rely on its stability, security and accuracy in their lab testing.

It proved such a success for Tx3, that the company was acquired in a nine-figured deal that was a huge win for the team.